| Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease RM Gadaleta, KJ Van Erpecum, B Oldenburg, ECL Willemsen, W Renooij, ... Gut 60 (4), 463-472, 2011 | 813 | 2011 |
| Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon N Ijssennagger, C Belzer, GJ Hooiveld, J Dekker, SWC van Mil, M Müller, ... Proceedings of the National Academy of Sciences 112 (32), 10038-10043, 2015 | 428 | 2015 |
| Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11 SWC van Mil, WL van der Woerd, G van der Brugge, E Sturm, ... Gastroenterology 127 (2), 379-384, 2004 | 409 | 2004 |
| Characterization of mutations in ATP8B1 associated with hereditary cholestasis LWJ Klomp, JC Vargas, SWC van Mil, L Pawlikowska, SS Strautnieks, ... Hepatology 40 (1), 27-38, 2004 | 338 | 2004 |
| Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy SWC Van Mil, A Milona, PH Dixon, R Mullenbach, VL Geenes, ... Gastroenterology 133 (2), 507-516, 2007 | 306 | 2007 |
| Sulfide as a mucus barrier-breaker in inflammatory bowel disease? N Ijssennagger, R van der Meer, SWC van Mil Trends in molecular medicine 22 (3), 190-199, 2016 | 283 | 2016 |
| Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy PH Dixon, SWC Van Mil, J Chambers, S Strautnieks, RJ Thompson, ... Gut 58 (4), 537-544, 2009 | 253 | 2009 |
| Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: no catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after … P Lykavieris, S van Mil, D Cresteil, M Fabre, M Hadchouel, L Klomp, ... Journal of hepatology 39 (3), 447-452, 2003 | 204 | 2003 |
| Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-[kappa] B signalling in the intestine RM Gadaleta, B Oldenburg, ECL Willemsen, M Spit, S Murzilli, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 2011 | 199 | 2011 |
| Protein fermentation in the gut; implications for intestinal dysfunction in humans, pigs, and poultry MS Gilbert, N Ijssennagger, AK Kies, SWC van Mil American Journal of Physiology-Gastrointestinal and Liver Physiology, 2018 | 170 | 2018 |
| Bile acids and their nuclear receptor FXR: relevance for hepatobiliary and gastrointestinal disease RM Gadaleta, SWC van Mil, B Oldenburg, PD Siersema, LWJ Klomp, ... Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2010 | 170 | 2010 |
| Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy WL van der Woerd, SWC van Mil, JM Stapelbroek, LWJ Klomp, ... Best practice & research Clinical gastroenterology 24 (5), 541-553, 2010 | 163 | 2010 |
| FIC1 disease: a spectrum of intrahepatic cholestatic disorders SWC van Mil, LWJ Klomp, LN Bull, RHJ Houwen Seminars in liver disease 21 (04), 535-544, 2001 | 161 | 2001 |
| FIC1, the protein affected in two forms of hereditary cholestasis, is localized in the cholangiocyte and the canalicular membrane of the hepatocyte EF Eppens, SWC van Mil, JML de Vree, KS Mok, JA Juijn, RPJO Elferink, ... Journal of hepatology 35 (4), 436-443, 2001 | 156 | 2001 |
| Anti-inflammatory and metabolic actions of FXR: insights into molecular mechanisms DAA Hollman, A Milona, KJ van Erpecum, SWC van Mil Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2012 | 134 | 2012 |
| Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease RM Nijmeijer, RM Gadaleta, SWC van Mil, AA van Bodegraven, ... PloS one 6 (8), e23745, 2011 | 126 | 2011 |
| Progress and challenges of selective Farnesoid X Receptor modulation V Massafra, R Pellicciari, A Gioiello, SWC van Mil Pharmacology & therapeutics 191, 162-177, 2018 | 122 | 2018 |
| Farnesoid X receptor: A “homeostat” for hepatic nutrient metabolism V Massafra, SWC van Mil Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (1), 45-59, 2018 | 114 | 2018 |
| Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta … FE Mózes, JA Lee, Y Vali, O Alzoubi, K Staufer, M Trauner, R Paternostro, ... The Lancet Gastroenterology & Hepatology 8 (8), 704-713, 2023 | 113 | 2023 |
| Gut microbial diversity is reduced in smokers with Crohn's disease JL Opstelten, J Plassais, SWC van Mil, E Achouri, M Pichaud, ... Inflammatory bowel diseases 22 (9), 2070-2077, 2016 | 113 | 2016 |